Richard Snyder | KAMRA I Venture Partner
Kineticos Life Sciences

Richard Snyder, Ph.D. is a Venture Partner at the Kineticos AMR Accelerator Fund I. He is also the Vice
President for Science and Technology, Pharma Services at ThermoFisher Scientific where he scientifically
leads the S&T Team’s initiative developing multi‐generational manufacturing and analytical platforms
used for the GMP production of Advanced Therapies (viral vector‐based gene therapies, molecular
therapies, modified cell‐based therapies) utilized in in vivo and ex vivo human therapeutics. Dr. Snyder
Joined ThermoFisher Scientific through the acquisition of Brammer Bio in 2019 which he co‐founded and
served as the Chief Scientific Officer. He has been investigating virus biology, vector development,
cGMP vector manufacturing and analytical technologies, and viral vector‐mediated gene transfer for
over 37 years and was a member of teams who developed novel viral vector‐based human gene
therapies. Dr. Snyder was a tenured Associate Professor of Molecular Genetics and Microbiology, and
Director of Biotherapeutic Programs at the University of Florida; an Assistant Professor of Pediatrics
at Harvard Medical School; and was previously employed by Cell Genesys, Somatix,
Merlin, and Avigen where he was engaged in the development of gene transfer vector and vaccine
technology, along with therapeutic applications. He has authored over 80 scientific publications and 8
US patents. Dr. Snyder was a postdoctoral fellow at Johns Hopkins University School of Medicine,
received his doctoral degree in Microbiology from The State University of New York at Stony Brook, and
obtained his B.A. in Biology from Washington University in St. Louis.